STAT5 interferes with PD-1 transcriptional activation and affects CD8+ T-cell sensitivity to PD-1-dependent

Guanning Wang1, Masaki Tajima1, Tasuku Honjo2

  • 1Department of Immunology, Foundation for Biomedical Research and Innovation at Kobe, Kobe 650-0047, Japan.

International Immunology
|August 28, 2021
PubMed

Insights

Interleukin-2 (IL-2) reduces Programmed Cell Death-1 (PD-1) expression on T cells by influencing transcription factors. This reduction enhances CD8+ T-cell anti-tumor activity.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Programmed Cell Death-1 (PD-1) is a crucial co-inhibitory receptor that regulates T-cell immune responses.
  • PD-1 expression on T cells is generally activation-dependent, but the precise role of cytokines in its regulation remains incompletely understood.
  • Understanding cytokine-mediated regulation of PD-1 is vital for optimizing T-cell-based immunotherapies.

Purpose of the Study:

  • To investigate the effect of Interleukin-2 (IL-2) on the regulation of Programmed Cell Death-1 (PD-1) expression in T cells.
  • To elucidate the molecular mechanisms underlying IL-2-mediated modulation of PD-1 transcription.
  • To assess the functional consequences of altered PD-1 expression on CD8+ T-cell activity.

Main Methods:

  • Polyclonal T-cell activation models were employed to study cytokine-dependent PD-1 regulation.
  • Bioinformatic analysis identified a conserved PD-1 promoter domain potentially involving NFAT and STAT5 transcription factors.
  • Chromatin immunoprecipitation (ChIP) assays were used to analyze the binding of NFAT and STAT5 to the PD-1 promoter in activated T cells.

Main Results:

  • IL-2 significantly inhibited the transcriptional up-regulation of PD-1, even while promoting T-cell activation.
  • IL-2 treatment led to decreased binding of NFAT1 and NFAT2, and increased binding of STAT5 to a specific PD-1 promoter region.
  • Overexpression of STAT5A demonstrated the ability to suppress NFAT1-driven PD-1 up-regulation in a sequence-specific manner.

Conclusions:

  • IL-2 reduces PD-1 expression on T cells, thereby enhancing CD8+ T-cell activity against PD-L1-expressing targets.
  • A competitive binding mechanism between NFAT and STAT5 transcription factors at the PD-1 promoter is proposed to mediate IL-2's regulatory effect.
  • Cytokine-driven competition among transcriptional factors offers a potential mechanism for fine-tuning PD-1 expression and immune responses.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
5.0K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
10.8K